Conti v. Doe

CourtDistrict Court, S.D. New York
DecidedOctober 21, 2020
Docket1:17-cv-09268
StatusUnknown

This text of Conti v. Doe (Conti v. Doe) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Conti v. Doe, (S.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT D DO AC TE # : F ILED: 10/21 /2020 SOUTHERN DISTRICT OF NEW YORK ------------------------------------------------------------ X DR. PAUL M. CONTI, : : Plaintiff and Counterclaim Defendant, : : 17-CV-9268 (VEC) : -against- : OPINION : JOHN DOE, : : Defendant and Counterclaim Plaintiff. : ----------------------------------------------------------- X VALERIE CAPRONI, United States District Judge: This action stems from a series of insulting and profane messages sent by Defendant John Doe to his former psychiatrist, Dr. Paul Conti. Dr. Conti sued Doe for defamation based on the messages.1 Am. Compl., Dkt. 31. Doe counterclaimed for breach of fiduciary duty, arguing that Dr. Conti breached the duty of doctor-patient confidentiality by disclosing his medical information in the amended complaint. Answer, Dkt. 59. Now before the Court are: (i)Plaintiff’s motion to exclude the opinion and testimony of Defendant’s experts Drs. Paul Appelbaum and Ziv Cohen, and (ii) Defendant’s motion to exclude portions of the opinion and testimony of Plaintiff’s rebuttal expert Dr. Donald Meyer. Dkts. 186, 191. For the following reasons, both motions are GRANTED in part and DENIED in part.

1 The Court previously dismissed Dr. Conti’s claims for intentional infliction of emotional distress, slander, and violations of various state criminal statutes. See Dkts. 57, 61. BACKGROUND2 Dr. Conti, a psychiatrist, began treating Defendant John Doe in May 2016 for drug addiction and erratic, threatening, and destructive behavior. See Am. Compl. ¶¶ 3, 10, 16-19. By late 2016, Dr. Conti had diagnosed Doe with “Narcissistic Personality Disorder, including

Borderline and Antisocial traits.” Id. ¶¶ 3, 24-25. Dr. Conti recommended that Doe wean himself from Xanax and that his parents “set behavioral boundaries” for him. See id. ¶¶ 26, 28. Despite Dr. Conti’s recommendations, Doe continued to abuse Xanax and to engage in destructive behavior. See id. ¶ 27. On April 6, 2017, Dr. Conti terminated his treatment of Doe; Dr. Conti explained to Doe and his parents that he could not continue to treat Doe because Doe was continuing to abuse drugs, refusing to comply with Dr. Conti’s treatment program, and sending Dr. Conti hostile text messages.3 See id. ¶¶ 35–36; Ex. D. Between April and November 2017, Doe continued to send Dr. Conti profane emails and text messages accusing Plaintiff, inter alia, of committing “fraud” and “malpractice.” See id. ¶¶ 35–51; Exs. B–I. Doe stated that his parents had “caught” Dr. Conti “red handed” committing

misconduct. Id. Exs. C, I, J. In several emails, Doe claimed that Dr. Conti had “abandoned” him by being “unreachable” when Doe was attempting to reduce his use of Xanax. Id. Ex. C. Doe

2 The Court will refer to the relevant submissions as follows: Dr. Conti’s Memorandum of Law in support of his motion to preclude expert testimony, Dkt. 190 as “Conti Mem. of Law”; Dr. Conti’s Reply Memorandum of Law in support of his motion to preclude expert testimony, Dkt. 210 as “Conti Reply”; Dr. Conti’s Deposition, Dkt. 203- 1 as “Conti Dep.”; Dr. Appelbaum’s Expert Report, Dkt 192-1 as “Appelbaum Report”; Dr. Appelbaum’s Deposition, Dkt. 192-5 as “Appelbaum Dep.”; Dr. Cohen’s Expert Report, Dkt. 190-1 as “Cohen Report”; Doe’s Memorandum of Law in support of his partial motion to preclude rebuttal expert testimony, Dkt. 188 as “Doe’s Mem. of Law”; Dr. Meyer’s Expert Report, Dkt. 187 as “Meyer Report”; Dr. Meyer’s Deposition, Dkt. 187-2 as “Meyer Dep.”.

3 On April 6, 2017, Doe sent Dr. Conti a text message, stating: “Let me say one thing to first start. Your one big f*****g fraud. You’re a f*****g con. That’s it. A f*****g fraud. What the narrative you put on me about being a gambler??? Addicted to xanax?? You dumb f**k Steve wonder could see that from a f*****g mile you little f*****g f*****t.” Am. Compl. ¶ 35. Dr. Conti terminated treatment later the same day. Id. ¶¶ 35–36. claimed that Dr. Conti’s actions led him to “relapse” in his drug abuse and caused him severe “mental pain.” Id. ¶¶ 40-44, 50; Exs. E, F, H, I, M-O. Doe also sent Dr. Conti messages threatening to “ruin [his] name,” and to bring legal action against him. See, e.g., id. Ex. A (“I will own you in a Courtroom”); Ex. H (“I’m advising

you get a legel [sic] team because I’m coming with everything I can . . . .”); Ex. J (“Get your legel [sic] team because I’m getting mine…I’m going to ruin your f******g name.”); Ex. O (“I’m going to do everything in the power of the law to destroy [you]”). Doe warned that he would “drain [Conti] of all of [his] resources,” that he would “bury [his] a** alive,” that he was “coming for [Conti],” and that Dr. Conti should “f*****g fear [Doe]” because he was “going to destroy [Conti’s] a**.” See id. Exs. H, K, L. Doe copied numerous third parties on these emails, including an attorney on faculty at Harvard Law School, several professors of psychiatry, Doe’s parents, and various members of Dr. Conti’s psychiatry practice. See id. ¶¶ 6, 37, 39, 42–45, 50– 51. Dr. Conti brought this action for defamation, seeking both monetary and injunctive relief.

Doe counterclaimed for breach of fiduciary duty, arguing that Dr. Conti breached his duty of confidentiality by “unnecessarily disclosing – indeed, weaponizing – Doe’s confidential medical information for personal financial gain.” See Dkt. 59 ¶¶ 94-106. I. Defendant’s Expert Dr. Appelbaum Dr. Conti seeks to exclude the report and testimony of Doe’s psychiatric ethics expert, Dr. Appelbaum. Dr. Appelbaum’s report concludes, inter alia, that Dr. Conti “did not meet the applicable professional standard of ethical conduct” when he: (i) responded to Doe’s messages by commencing a lawsuit against Doe; (ii) disclosed more of Doe’s confidential information in the lawsuit than could be ethically justified; and (iii) transferred Doe’s care to a new treating psychiatrist.4 Appelbaum Report ¶¶ 4, 10. Dr. Appelbaum opines that Dr. Conti failed to recognize Doe’s threatening messages as a “manifestation of [Doe’s] transference.”5 Id. ¶ 11. As a result, Dr. Appelbaum states that Dr. Conti “acted out his [own] countertransference”6 in response to the messages rather than

managing the situation “in a manner consistent with professional ethical standards.” Id. Dr. Appelbaum explains that a “psychiatrist acting consistent with professional standards of care,” would take various steps after receiving threats from a patient, including: (i) consulting someone with experience evaluating patient threats; (ii) facilitating a meeting between the patient and the patient’s family; (iii) alerting law enforcement; (iv) notifying his malpractice insurer; and (v) increasing security at his home and office. Id. ¶¶ 12-15. Because Dr. Conti did not take any of those steps, Dr. Appelbaum concludes that the “decision to respond to [Doe’s] messages by filing the lawsuit … was both disproportionate to the ‘threat’ posed by Doe, and inconsistent with Dr. Conti’s stated fears of physical assault and legal liability.”7 Id. ¶ 15. Moreover, Dr.

4 The Appelbaum Report indicates four opinions by breaking what the Court views as one opinion (Dr. Conti did not adhere to ethical standards by responding to Doe’s messages by filing a lawsuit) into two opinions (Dr. Conti did not adhere to ethical standards “with respect to: (1) responding to his former patient John Doe’s behavior when the patient sent him the Messages; [and] (2) evaluating whether to commence a lawsuit against Doe in response to the Messages.”) Appelbaum Report ¶ 10. For purposes of the litigation, items one and two in Appelbaum’s Report really collapse into a single opinion that Conti acted unethically by responding to Doe’s messages with a lawsuit rather than with any number of less drastic actions. See id. ¶¶ 11-16.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
In Re Paoli Railroad Yard PCB Litigation
35 F.3d 717 (Third Circuit, 1994)
United States v. Vinal S. Duncan
42 F.3d 97 (Second Circuit, 1994)
United States v. Tin Yat Chin, AKA Tan C. Dau
371 F.3d 31 (Second Circuit, 2004)
Tarasoff v. Regents of University of California
551 P.2d 334 (California Supreme Court, 1976)
United States v. Williams
506 F.3d 151 (Second Circuit, 2007)
In Re Fosamax Products Liability Litigation
645 F. Supp. 2d 164 (S.D. New York, 2009)
In Re Rezulin Products Liability Litigation
309 F. Supp. 2d 531 (S.D. New York, 2004)
In Re Zyprexa Products Liability Litigation
489 F. Supp. 2d 230 (E.D. New York, 2007)
Carter v. United States
760 F. Supp. 2d 281 (E.D. New York, 2011)
Bialik v. E. I. Dupont De Mours & Co.
142 Misc. 2d 926 (New York Supreme Court, 1988)
Chanko v. American Broadcasting Companies, Inc.
49 N.E.3d 1171 (New York Court of Appeals, 2016)
Tobin v. Steisel
475 N.E.2d 101 (New York Court of Appeals, 1985)
Juric v. Bergstraesser
44 A.D.3d 1186 (Appellate Division of the Supreme Court of New York, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Conti v. Doe, Counsel Stack Legal Research, https://law.counselstack.com/opinion/conti-v-doe-nysd-2020.